Baloxavir, compared with oseltamivir, was associated with lower health care resource utilization and costs in patients with influenza, particularly those at high risk of secondary complications.
Devika Chawla, PhD, MSPH
Advertisement
Articles by Devika Chawla, PhD, MSPH
Advertisement
Latest Updated Articles
- Baloxavir vs Oseltamivir: Reduced Utilization and Costs in Influenza
Published: November 5th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Boosting RSV Vaccination in Older Adults Could Save Thousands
3
Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes
4
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
5
